Revive Therapeutics Ltd. (31R)
Munich
Delayed Data
Oct 14, 2026, 06:00 AM
Day's Range
0.017552 wk Range
0.00050Overview - 31R - Revive Therapeutics Ltd.
Key Statistics
Valuation
P/E (Trailing)
‪-0.58‬
Price / Book
‪-1.89‬
Profitability
Return on Assets
‪-5,370.77%‬
Return on Equity
‪318.64%‬
Ownership
Shares Outstanding
435.67M
Price stats
50-Day Avg
‪0.0219‬
200-Day Avg
‪0.0157‬
Peers - 31R - Revive Therapeutics Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
- 31RMunichRevive Therapeutics Ltd.+48.57%52-week change-0.58P/E (Trailing)—Profit Margin
- 3KFMunichAuxly Cannabis Group Inc.+95.03%52-week change5.14P/E (Trailing)‪57.26%‬Profit Margin
- HLSMunichAIC Mines Limited+50.81%52-week change—P/E (Trailing)—Profit Margin
- PA8MunichPaion AG+74.44%52-week change-0.83P/E (Trailing)‪94.10%‬Profit Margin
- I76MunichIronwood Pharmaceuticals, Inc. Class A Common Stock+61.59%52-week change21.87P/E (Trailing)—Profit Margin
- NGQ1MunichMedicure Inc.+60.89%52-week change-2.63P/E (Trailing)‪40.71%‬Profit Margin
- 0L8MunichLantheus Holdings Inc.+50.44%52-week change25.20P/E (Trailing)‪61.10%‬Profit Margin
Profile Summary - 31R - Revive Therapeutics Ltd.
About
Revive Therapeutics Ltd. is a life sciences company engaged in the research and development of novel therapies and technologies aimed at addressing unmet medical needs. The company primarily focuses on rare disorders and infectious diseases, undertaking initiatives to develop and improve existing treatments through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
